SCHEMBL5121672

SCHEMBL5121672

CC(C)NS(=O)(=O)Cc1ccc(CN)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSIP1 O75475 1/20 0.44
MEN1 O00255 1/20 0.44
ALDH1A1 P00352 1/20 0.44
HTT P42858 1/20 0.44
KMT2A Q03164 1/20 0.44
CA1 P00915 3/20 0.42
CA2 P00918 3/20 0.42
CA9 Q16790 2/20 0.42
CA12 O43570 1/20 0.42
CA4 P22748 1/20 0.42
CA6 P23280 1/20 0.42
CA5A P35218 1/20 0.42
CA7 P43166 1/20 0.42
CA14 Q9ULX7 1/20 0.42
CA5B Q9Y2D0 1/20 0.42
MAPT P10636 1/20 0.41
SLC1A3 P43003 1/20 0.41
SLC1A2 P43004 1/20 0.41
SLC1A1 P43005 1/20 0.41
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4637575 0.86 ALDH1A1 (0.43) MEN1ALDH1A1HTTKMT2ASLC1A3
SCHEMBL2993430 0.85 ALDH1A1 (0.44) MEN1ALDH1A1HTTKMT2ACA1
SCHEMBL18571231 0.83 KMT2A (0.45) MEN1ALDH1A1HTTKMT2ACA1
SCHEMBL16000110 0.83 ALDH1A1 (0.45) MEN1ALDH1A1HTTKMT2ACA1
SCHEMBL10494811 0.82 ALDH1A1 (0.44) MEN1ALDH1A1HTTKMT2ACA1
SCHEMBL16000109 0.81 KDM4E (0.50) MEN1ALDH1A1HTTKMT2AKDM4E
SCHEMBL18571235 0.81 KMT2A (0.44) MEN1ALDH1A1HTTKMT2AMAPT
SCHEMBL13234055 0.81 KMT2A (0.49) MEN1ALDH1A1HTTKMT2ACA1
SCHEMBL18571269 0.81 ALDH1A1 (0.44) MEN1ALDH1A1HTTKMT2AMAPT
SCHEMBL5121670 0.81 ALDH1A1 (0.44) MEN1ALDH1A1HTTKMT2ACA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8729089-B2 Pyrido(3,2-d)pyrimidines useful for treating viral infections GILEAD SCIENCES, INC. (US) 2014-05-20 US claimed
US-8729089-B2 Pyrido(3,2-d)pyrimidines useful for treating viral infections GILEAD SCIENCES, INC. (US) 2014-05-20 US disclosed
US-20080182870-A1 PYRIDO(3,2-d)PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS GILEAD SCIENCES, INC. (US) 2008-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080182870-A1 PYRIDO(3,2-d)PYRIMIDINES USEFUL FOR TREATING VIRAL INFECTIONS PNPO, DPYD, PNP PSIP1 1173/4885MEN1 2912/4885ALDH1A1 1142/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.